By Professor Monica M. Lahra

Journal articles

Ebeyan S; Windsor M; Bordin A; Mhango L; Erskine S; Trembizki E; Mokany E; Tan LY; Whiley D; Cunningham P; Wand H; Donovan B; Kaldor J; Conway D; Ryder N; McNulty A; Templeton D; Guy R; Lahra M; Gunathilake M, 2019, 'Evaluation of the ResistancePlus GC (beta) assay: A commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae', Journal of Antimicrobial Chemotherapy, 74, pp. 1820 - 1824, http://dx.doi.org/10.1093/jac/dkz108

Lahra MM; Enriquez R; George CRR, 2019, 'Australian Gonococcal Surveillance Programme Annual Report, 2017', Communicable diseases intelligence (2018), 43, http://dx.doi.org/10.33321/cdi.2019.43.13

George CRR; Enriquez RP; Gatus BJ; Whiley DM; Lo YR; Ishikawa N; Wi T; Lahra MM, 2019, 'Systematic review and survey of Neisseria gonorrhoeae ceftriaxone and azithromycin susceptibility data in the Asia Pacific, 2011 to 2016', PLoS ONE, 14, http://dx.doi.org/10.1371/journal.pone.0213312

Jennison AV; Whiley D; Lahra MM; Graham RM; Cole MJ; Hughes G; Fifer H; Andersson M; Edwards A; Eyre D, 2019, 'Genetic relatedness of ceftriaxone-resistant and highlevel azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018', Eurosurveillance, 24, http://dx.doi.org/10.2807/1560-7917.ES.2019.24.8.1900118

Yeo KT; Lahra M; Bajuk B; Hilder L; Abdel-Latif ME; Wright IM; Oei JL, 2019, 'Long-term outcomes after group B streptococcus infection: A cohort study', Archives of Disease in Childhood, 104, pp. 172 - 178, http://dx.doi.org/10.1136/archdischild-2017-314642

Kiatchoosakun P; Jirapradittha J; Sirikarn P; Laopaiboon M; Pattanittum P; Chandrakachorn W; Srirojana S; Jeffery H; Green S; Lumbiganon P, 2019, 'Early-Onset Neonatal Sepsis and Antibiotic Use in Northeast Thailand', American Journal of Perinatology, 36, pp. 1295 - 1303, http://dx.doi.org/10.1055/s-0038-1676829

Buckley C; Beatson SA; Limnios A; Lahra MM; Whiley DM; Forde BM, 2019, 'Whole-genome sequencing as an improved means of investigating Neisseria gonorrhoeae treatment failures', Sexual Health, 16, pp. 500 - 507, http://dx.doi.org/10.1071/SH19012

Unemo M; Lahra MM; Cole M; Galarza P; Ndowa F; Martin I; Dillon JAR; Ramon-Pardo P; Bolan G; Wi T, 2019, 'World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): Review of new data and evidence to inform international collaborative actions and research efforts', Sexual Health, 16, pp. 412 - 425, http://dx.doi.org/10.1071/SH19023

George CRR; Enriquez RP; Gatus BJ; Whiley DM; Lo Y-R; Ishikawa N; Wi T; Lahra MM, 2019, 'Systematic review and survey of neisseria gonorrhoeae antimicrobial resistance data in the Asia Pacific, 2011 to 2016', Pathology, 51, pp. S136 - S136, http://dx.doi.org/10.1016/j.pathol.2018.12.395

Buckley C; Forde BM; Trembizki E; Lahra MM; Beatson SA; Whiley DM, 2018, 'Use of whole genome sequencing to investigate an increase in Neisseria gonorrhoeae infection among women in urban areas of Australia', Scientific Reports, 8, http://dx.doi.org/10.1038/s41598-018-20015-x

Regan DG; Hui BB; Wood JG; Fifer H; Lahra MM; Whiley DM, 2018, 'Treatment for pharyngeal gonorrhoea under threat', The Lancet Infectious Diseases, 18, pp. 1175 - 1177, http://dx.doi.org/10.1016/S1473-3099(18)30610-8

Whiley DM; Mhango L; Jennison AV; Nimmo G; Lahra MM, 2018, 'Direct detection of penA gene associated with ceftriaxone-resistant neisseria gonorrhoeae FC428 strain by using PCR', Emerging Infectious Diseases, 24, pp. 1573 - 1575, http://dx.doi.org/10.3201/eid2408.180295

Whiley DM; Jennison A; Pearson J; Lahra MM, 2018, 'Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin', The Lancet Infectious Diseases, 18, pp. 717 - 718, http://dx.doi.org/10.1016/S1473-3099(18)30340-2

Whiley DM; Kundu RL; Jennison AV; Buckley C; Limnios A; Hogan T; Enriquez R; El Nasser J; Robert George C; Lahra MM, 2018, 'Azithromycin-resistant Neisseria gonorrhoeae spreading amongst men who have sex with men (MSM) and heterosexuals in New South Wales, Australia, 2017', Journal of Antimicrobial Chemotherapy, 73, pp. 1242 - 1246, http://dx.doi.org/10.1093/jac/dky017

Lahra MM; Martin I; Demczuk W; Jennison AV; Lee KI; Nakayama SI; Lefebvre B; Longtin J; Ward A; Mulvey MR; Wi T; Ohnishi M; Whiley D, 2018, 'Cooperative recognition of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain', Emerging Infectious Diseases, 24, pp. 735 - 740, http://dx.doi.org/10.3201/eid2404.171873

Lahra MM; Enriquez R, 2018, 'Australian Gonococcal Surveillance Programme Annual Report, 2016', Communicable diseases intelligence (2018), 42

Watson S; Cabrera-Aguas M; Khoo P; Pratama R; Gatus BJ; Gulholm T; El-Nasser J; Lahra MM, 2018, 'Keratitis antimicrobial resistance surveillance program, Sydney, Australia: 2016 Annual Report', Clinical and Experimental Ophthalmology, 47, pp. 20 - 25, http://dx.doi.org/10.1111/ceo.13364

George CRR; Rockett R; Whiley DM; Enriquez RP; Kundu R; El-Nasser J; Sintchenko V; Lahra MM, 2018, 'Whole genome sequencing to characterise azithromycin resistant Neisseria gonorrhoeae from New South Wales in 2017', Pathology, 50, pp. S51 - S51, http://dx.doi.org/10.1016/j.pathol.2017.12.117

Lahra MM; Enriquez R, 2017, 'Australian Meningococcal Surveillance Programme annual report, 2016', Communicable diseases intelligence quarterly report, 41, pp. E369 - E382

Archer BN; Chiu CK; Jayasinghe SH; Richmond PC; McVernon J; Lahra MM; Andrews RM; McIntyre PB; Nissen M; Campbell-Lloyd S; Peterson K; Koehler A; Leask J, 2017, 'Epidemiology of invasive meningococcal b disease in Australia, 1999-2015: Priority populations for vaccination', Medical Journal of Australia, 207, pp. 382 - 387, http://dx.doi.org/10.5694/mja16.01340

Lahra MM; George CRR; Whiley DM, 2017, 'The Australian Gonococcal Surveillance Programme 1979-2017', MICROBIOLOGY AUSTRALIA, 38, pp. 175 - 179, http://dx.doi.org/10.1071/MA17062

Lahra MM; Enriquez R, 2017, 'Australian Meningococcal Surveillance Programme, 1 April to 30 June 2017', Communicable diseases intelligence quarterly report, 41, pp. E241 - E242

Lahra MM; Enriquez R, 2017, 'MENINGOCOCCAL SURVEILLANCE AUSTRALIA REPORTING PERIOD 1 APRIL TO 30 JUNE 2017', COMMUNICABLE DISEASES INTELLIGENCE, 41, pp. E241 - E242, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000423988300009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Whiley DM; Trembizki E; Buckley C; Freeman K; Baird RW; Beaman M; Chen M; Donovan B; Kundu RL; Fairley CK; Guy R; Hogan T; Kaldor JM; Karimi M; Limnios A; Regan DG; Ryder N; Su JY; Ward J; Lahra MM, 2017, 'Molecular antimicrobial resistance surveillance for Neisseria gonorrhoeae, Northern Territory, Australia', Emerging Infectious Diseases, 23, pp. 1478 - 1485, http://dx.doi.org/10.3201/eid2309.170427

Wi T; Lahra MM; Ndowa F; Bala M; Dillon JAR; Ramon-Pardo P; Eremin SR; Bolan G; Unemo M, 2017, 'Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action', PLoS Medicine, 14, pp. e1002344, http://dx.doi.org/10.1371/journal.pmed.1002344

Alirol E; Wi TE; Bala M; Bazzo ML; Chen XS; Deal C; Dillon JAR; Kularatne R; Heim J; Hooft van Huijsduijnen R; Hook EW; Lahra MM; Lewis DA; Ndowa F; Shafer WM; Tayler L; Workowski K; Unemo M; Balasegaram M, 2017, 'Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines', PLoS Medicine, 14, http://dx.doi.org/10.1371/journal.pmed.1002366

Lahra MM, 2017, 'Australian Meningococcal Surveillance Programme, 1 January to 31 March 2017', Communicable diseases intelligence quarterly report, 41, pp. E201

Lahra MM; Enriquez RP, 2017, 'Australian Gonococcal Surveillance Programme annual report, 2015', Communicable diseases intelligence quarterly report, 41

Lahra MM; Trembizki E; Buckley C; Donovan B; Chen M; Guy R; Kundu RL; Regan DG; Whiley DM, 2017, 'Changes in the rates of Neisseria gonorrhoeae antimicrobial resistance are primarily driven by dynamic fluctuations in common gonococcal genotypes', Journal of Antimicrobial Chemotherapy, 72, pp. 705 - 711, http://dx.doi.org/10.1093/jac/dkw452

Goire N; Kundu R; Trembizki E; Buckley C; Hogan TR; Lewis DA; Branley JM; Whiley DM; Lahra MM, 2017, 'Mixed gonococcal infections in a high-risk population, Sydney, Australia 2015: Implications for antimicrobial resistance surveillance?', Journal of Antimicrobial Chemotherapy, 72, pp. 407 - 409, http://dx.doi.org/10.1093/jac/dkw406

Lahra MM; Ward A; Trembizki E; Hermanson J; Clements E; Lawrence A; Whiley D, 2017, 'Treatment guidelines after an outbreak of azithromycin-resistant Neisseria gonorrhoeae in South Australia', The Lancet Infectious Diseases, 17, pp. 133 - 134, http://dx.doi.org/10.1016/S1473-3099(17)30007-5

Bartlett AW; Smith B; George CRR; McMullan B; Kesson A; Lahra MM; Palasanthiran P, 2017, 'Epidemiology of Late and Very Late Onset Group B Streptococcal Disease: Fifteen-Year Experience from Two Australian Tertiary Pediatric Facilities', Pediatric Infectious Disease Journal, 36, pp. 20 - 24, http://dx.doi.org/10.1097/INF.0000000000001345

Lahra MM, 2017, 'Antimicrobial resistance in Neisseria gonorrhoeae in Australia', Pathology, 49, pp. S51 - S51, http://dx.doi.org/10.1016/j.pathol.2016.12.123

Goire N; Kundu R; Trembizki E; Buckley C; Hogan TR; Lewis DA; Branley JM; Whiley DM; Lahra MM, 2017, 'Mixed gonococcal infections and antimicrobial resistance surveillance', Pathology, 49, pp. S115 - S115, http://dx.doi.org/10.1016/j.pathol.2016.12.337

Lahra MM; Enriquez RP, 2016, 'Australian Gonococcal Surveillance Programme, 1 April to 30 June 2016', Communicable diseases intelligence quarterly report, 40, pp. E557 - E559

Lahra MM; Enriquez RP, 2016, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2016', Communicable diseases intelligence quarterly report, 40, pp. E554 - E556

Lahra MM; Enriquez RP, 2016, 'Australian Meningococcal Surveillance Programme annual report, 2015', Communicable diseases intelligence quarterly report, 40, pp. E503 - E511

Lahra MM; Enriquez RP, 2016, 'Australian Meningococcal Surveillance Programme, 1 July to 30 September 2016', Communicable diseases intelligence quarterly report, 40, pp. E560

Martin NV; Ong KS; Howden BP; Lahra MM; Lambert SB; Beard FH; Dowse GK; Saul N, 2016, 'Rise in invasive serogroup W meningococcal disease in Australia 2013-2015', Communicable diseases intelligence quarterly report, 40, pp. E454 - E459

Trembizki E; Wand H; Donovan B; Chen M; Fairley CK; Freeman K; Guy R; Kaldor JM; Lahra MM; Lawrence A; Lau C; Pearson J; Regan DG; Ryder N; Smith H; Stevens K; Su JY; Ward J; Whiley DM, 2016, 'The Molecular Epidemiology and Antimicrobial Resistance of Neisseria gonorrhoeae in Australia: A Nationwide Cross-Sectional Study, 2012', Clinical Infectious Diseases, 63, pp. 1591 - 1598, http://dx.doi.org/10.1093/cid/ciw648

Lahra MM; Dillon JAR; George CRR; Lewis DA; Wi TE; Whiley DM, 2016, 'From zero to zero in 100 years: Gonococcal antimicrobial resistance', Microbiology Today, 43, pp. 173 - 175, http://dx.doi.org/10.1071/MA16058

Buckley C; Trembizki E; Donovan B; Chen M; Freeman K; Guy R; Lahra MM; Kundu RL; Regan DG; Smith HV; Whiley DM; Kaldor J; Wand H; Ward J; Fairley C; Ryder N; Su JY, 2016, 'Real-time PCR detection of Neisseria gonorrhoeae susceptibility to penicillin', Journal of Antimicrobial Chemotherapy, 71, pp. 3090 - 3095, http://dx.doi.org/10.1093/jac/dkw291

Unemo M; Golparian D; Sánchez-Busó L; Grad Y; Jacobsson S; Ohnishi M; Lahra MM; Limnios A; Sikora AE; Wi T; Harris SR, 2016, 'The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: Phenotypic, genetic and reference genome characterization', Journal of Antimicrobial Chemotherapy, 71, pp. 3096 - 3108, http://dx.doi.org/10.1093/jac/dkw288

Hui BB; Whiley DM; Donovan B; Law MG; Regan DG; Chen M; Guy R; Lahra M; Han A, 2016, 'Identifying factors that lead to the persistence of imported gonorrhoeae strains: A modelling study', Sexually Transmitted Infections, 93, pp. 221 - 225, http://dx.doi.org/10.1136/sextrans-2016-052738

Lahra MM; Enriquez RP, 2016, 'Australian Meningococcal Surveillance Programme, 1 January to 31 March 2016', Communicable diseases intelligence quarterly report, 40, pp. E446

Enriquez RP; Goire N; Kundu R; Gatus BJ; Lahra MM, 2016, 'A comparison of agar dilution with the Calibrated Dichotomous Sensitivity (CDS) and Etest methods for determining the minimum inhibitory concentration of ceftriaxone against Neisseria gonorrhoeae', Diagnostic Microbiology and Infectious Disease, 86, pp. 40 - 43, http://dx.doi.org/10.1016/j.diagmicrobio.2016.04.016

Lahra MM; Enriquez RP, 2016, 'AUSTRALIAN MENINGOCOCCAL SURVEILLANCE PROGRAMMMME, 1 APRIL TO 30 JUNE 2016', COMMUNICABLE DISEASES INTELLIGENCE, 40, pp. E447 - E447, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000388538500018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lawrence GL; Wang H; Lahra M; Booy R; McIntyre PB, 2016, 'Meningococcal disease epidemiology in Australia 10 years after implementation of a national conjugate meningococcal C immunization programme', Epidemiology and Infection, 144, pp. 2382 - 2391, http://dx.doi.org/10.1017/S0950268816000704

Lahra MM; Enriquez RP, 2016, 'Australian Meningococcal Surveillance Programme annual report, 2014', Communicable diseases intelligence quarterly report, 40, pp. E221 - E228

Lahra MM; Enriquez RP, 2016, 'Australian Gonococcal Surveillance Programme, 1 July to 30 September 2015', Communicable diseases intelligence quarterly report, 40, pp. E179 - E181

Back to profile page